Genasys Inc.
Financial highlights
| Metric | FY 09/30/25 | FY 09/30/24 | FY 09/30/23 | FY 09/30/22 | FY 09/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $40.8M | $24.0M | $46.7M | $54.0M | $47.0M |
| Cost of revenue | $23.8M | $13.8M | $24.9M | $26.8M | $23.6M |
| Gross profit | $17.0M | $10.2M | $21.8M | $27.3M | $23.4M |
| Selling, general & administrative | $25.7M | $27.3M | $24.6M | $22.6M | $17.4M |
| Research and development | $8.1M | $9.6M | $8.1M | $7.0M | $4.9M |
| Operating expenses | $33.8M | $36.9M | $32.7M | $42.8M | $22.3M |
| Operating income | -$16.8M | -$26.7M | -$11.0M | -$15.5M | $1.1M |
| Interest expense | $1.6M | $603,000 | — | — | — |
| Pretax income | -$18.0M | -$32.1M | -$11.0M | -$15.5M | $1.1M |
| Income tax expense | $119,000 | -$405,000 | $7.4M | $741,000 | $434,000 |
| Net income | -$18.1M | -$31.7M | -$18.4M | -$16.2M | $704,000 |
| Balance Sheet | |||||
| Cash and equivalents | $8.0M | $4.9M | $8.7M | $12.7M | $13.2M |
| Current assets | $39.3M | $26.1M | $25.2M | $35.6M | $35.5M |
| Total assets | $63.9M | $53.9M | $49.9M | $71.9M | $90.1M |
| Current liabilities | $54.4M | $14.1M | $11.3M | $15.4M | $17.5M |
| Total liabilities | $61.7M | $36.4M | $16.1M | $21.5M | $24.2M |
| Stockholders' equity | $2.2M | $17.6M | $33.8M | $50.4M | $66.0M |
| Cash Flow Statement | |||||
| Cash from operations | -$8.8M | -$19.5M | -$9.6M | $468,000 | $6.2M |
| Depreciation and amortization | $422,000 | $2.9M | $2.6M | $2.6M | $1.6M |
| Stock-based compensation | $1.7M | $1.7M | $1.6M | $2.2M | $1.4M |
| Capital expenditure | $255,000 | $191,000 | $239,000 | $381,000 | $208,000 |
| Free cash flow | -$9.0M | -$19.6M | -$9.8M | $87,000 | $5.9M |
| Share repurchases | — | — | $0 | $998,000 | $0 |
| Impairments | $0 | $0 | $0 | $13.2M | $0 |
Shares outstanding 45.5M · Free float 75.6%
Annual filing data through FY ended September 30, 2025; float as of July 11, 2026.